GLS
NYSEGelesis Holdings Inc.
Latest news
25 items- SECGelesis Holdings Inc. filed SEC Form 8-K: Bankruptcy or Receivership, Leadership Update, Financial Statements and Exhibits8-K - GELESIS HOLDINGS, INC. (0001805087) (Filer)
- SECSEC Form CT ORDER filed by Gelesis Holdings Inc.CT ORDER - GELESIS HOLDINGS, INC. (0001805087) (Filer)
- 13D/GSEC Form SC 13D/A filed by Gelesis Holdings Inc. (Amendment)SC 13D/A - GELESIS HOLDINGS, INC. (0001805087) (Subject)
- SECGelesis Holdings Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Financial Statements and Exhibits8-K - GELESIS HOLDINGS, INC. (0001805087) (Filer)
- SECSEC Form SC 13E3/A filed by Gelesis Holdings Inc. (Amendment)SC 13E3/A - GELESIS HOLDINGS, INC. (0001805087) (Subject)
- SECSEC Form PRER14A filed by Gelesis Holdings Inc.PRER14A - GELESIS HOLDINGS, INC. (0001805087) (Filer)
- 13D/GSEC Form SC 13D/A filed by Gelesis Holdings Inc. (Amendment)SC 13D/A - GELESIS HOLDINGS, INC. (0001805087) (Subject)
- INSIDERSEC Form 4 filed by Puretech Health Plc4 - GELESIS HOLDINGS, INC. (0001805087) (Issuer)
- SECGelesis Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K - GELESIS HOLDINGS, INC. (0001805087) (Filer)
- SECSEC Form SC 13E3/A filed by Gelesis Holdings Inc. (Amendment)SC 13E3/A - GELESIS HOLDINGS, INC. (0001805087) (Subject)
- SECSEC Form PRER14A filed by Gelesis Holdings Inc.PRER14A - GELESIS HOLDINGS, INC. (0001805087) (Filer)
- SECGelesis Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - GELESIS HOLDINGS, INC. (0001805087) (Filer)
- SECGelesis Holdings Inc. filed SEC Form 8-K: Leadership Update8-K - GELESIS HOLDINGS, INC. (0001805087) (Filer)
- SECSEC Form 10-Q filed by Gelesis Holdings Inc.10-Q - GELESIS HOLDINGS, INC. (0001805087) (Filer)
- SECSEC Form SC 13E3 filed by Gelesis Holdings Inc.SC 13E3 - GELESIS HOLDINGS, INC. (0001805087) (Subject)
- SECSEC Form PREM14A filed by Gelesis Holdings Inc.PREM14A - GELESIS HOLDINGS, INC. (0001805087) (Filer)
- SECGelesis Holdings Inc. filed SEC Form 8-K: Leadership Update8-K - GELESIS HOLDINGS, INC. (0001805087) (Filer)
- SECSEC Form DEFA14A filed by Gelesis Holdings Inc.DEFA14A - GELESIS HOLDINGS, INC. (0001805087) (Filer)
- 13D/GSEC Form SC 13D/A filed by Gelesis Holdings Inc. (Amendment)SC 13D/A - GELESIS HOLDINGS, INC. (0001805087) (Subject)
- SECGelesis Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K - GELESIS HOLDINGS, INC. (0001805087) (Filer)
- SECSEC Form DEF 14A filed by Gelesis Holdings Inc.DEF 14A - GELESIS HOLDINGS, INC. (0001805087) (Filer)
- INSIDERSEC Form 4 filed by Puretech Health Plc4 - GELESIS HOLDINGS, INC. (0001805087) (Issuer)
- 13D/GSEC Form SC 13D/A filed by Gelesis Holdings Inc. (Amendment)SC 13D/A - GELESIS HOLDINGS, INC. (0001805087) (Subject)
- SECGelesis Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits8-K - GELESIS HOLDINGS, INC. (0001805087) (Filer)
- INSIDERSEC Form 4 filed by Puretech Health Plc4 - GELESIS HOLDINGS, INC. (0001805087) (Issuer)
GLS FAQ
6 questionsWhat does Gelesis Holdings Inc. do?
Gelesis Holdings Inc., a commercial stage biotherapeutics company, developing a biomimicry to treat the genesis of obesity and GI-related chronic diseases. The company also provides PLENITY, an orally administered, non-stimulant, and non-systemic aid for weight management. In addition, it offers a product for obesity and overweight and a pipeline with potential therapies for non-alcoholic fatty liver disease/non-alcoholic steatohepatitis, type 2 diabetes, and GS500 for Functional Constipation. Gelesis Holdings Inc. was incorporated in 2006 and is headquartered in Boston, Massachusetts.Where does GLS stock trade?
Gelesis Holdings Inc. (GLS) is listed on NYSE.What sector and industry is GLS in?
Gelesis Holdings Inc. operates in the Health Care sector, Biotechnology: Biological Products (No Diagnostic Substances) industry.When did Gelesis Holdings Inc. go public?
Gelesis Holdings Inc. (GLS) completed its IPO in 2020.What companies are similar to GLS?
Notable peers in the same industry include AMGN (Amgen Inc.), GILD (Gilead Sciences Inc.), ARGX (argenx SE), RVMD (Revolution Medicines Inc.), BIIB (Biogen Inc.). Compare GLS side-by-side with any of them on Quantisnow.How can I track GLS on Quantisnow?
Quantisnow aggregates Gelesis Holdings Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow GLS to receive live email and push alerts on every new disclosure.